{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:39:25Z","timestamp":1792539565935,"version":"4.5.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00213-025-06979-5","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T04:46:24Z","timestamp":1765341984000},"page":"2321-2338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The nitric oxide synthase inhibitor 7-nitroindazole attenuates social withdrawal and memory impairments induced by Blockade of the NMDA receptor in the rat"],"prefix":"10.1007","volume":"243","author":[{"given":"Angeliki Metaxia","family":"Styla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Begas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Pitsikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"6979_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3109\/09540261.2010.515205","volume":"22","author":"KM Abel","year":"2010","unstructured":"Abel KM, Drake R, Goldstein JM (2010) Sex differences in schizophrenia. Int Rev Psychiatry 22:417\u2013428","journal-title":"Int Rev Psychiatry"},{"key":"6979_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/archpsyc.1993.01820150007001","volume":"50","author":"S Akbarian","year":"1993","unstructured":"Akbarian S, Bunney WE, Potkin SG, Wigal SB, Hagman JO, Sandman CA, Jones EG (1993) Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 50:169\u2013177","journal-title":"Arch Gen Psychiatry"},{"key":"6979_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1042\/bj3570593","volume":"357","author":"WK Alderton","year":"2001","unstructured":"Alderton WK, Cooper CE, Knowles RG (2001) Nitric oxide synthases: structure function and inhibition. Biochem J 357:593\u2013615","journal-title":"Biochem J"},{"key":"6979_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pharep.2015.09.004","volume":"68","author":"A Anaeigouidari","year":"2016","unstructured":"Anaeigouidari A, Shoukhtanloo M, Shafei MN, Sadeghnia HR, Reisi P, Beheshti F, Behradnia S, Mousavi SM, Hosseini M (2016) Neural nitric oxide synthase has a role in the detrimental effects of lipopolysaccharide on spatial memory and synaptic plasticity in rats. Pharmacol Rep 68:243\u2013249","journal-title":"Pharmacol Rep"},{"key":"6979_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/bs.apha.2016.01.006","volume":"76","author":"DT Balu","year":"2016","unstructured":"Balu DT (2016) The NMDA receptor and schizophrenia: from pathophysiology to treatment. Adv Pharmacol 76:351\u2013382","journal-title":"Adv Pharmacol"},{"key":"6979_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0091-3057(95)02021-7","volume":"53","author":"L Bartolini","year":"1996","unstructured":"Bartolini L, Casamenti F, Pepeu G (1996) Aniracetam restores object recognition impaired by age, scopolamine and nucleus basalis lesions. Pharmacol Biochem Behav 53:277\u2013283","journal-title":"Pharmacol Biochem Behav"},{"key":"6979_CR7","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00702-004-0224-x","volume":"112","author":"V Bashkatova","year":"2005","unstructured":"Bashkatova V, Kraus MM, Vanin A, Hornick A, Philippu A, Prast H (2005) 7-nitroindazole, nNOS inhibitor, attenuates amphetamine-induced amino acid release and nitric oxide generation but not lipid peroxidation in the rat brain. J Neural Transm 112:779\u2013788","journal-title":"J Neural Transm"},{"key":"6979_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2174\/157340608784325124","volume":"4","author":"A Becker","year":"2008","unstructured":"Becker A, Grecksch G, Schwegler H, Roskoden T (2008) Expression of mRNA of neurotrophic factors and their receptors are significantly altered after subchronic ketamine treatment. Med Chem 4:256\u2013263","journal-title":"Med Chem"},{"key":"6979_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00292","volume":"6","author":"HC Bergstrom","year":"2015","unstructured":"Bergstrom HC, Darvesh AS, Berger SP (2015) Inducible oxide inhibitors block NMDA antagonist-stimulated motoric behaviors and medial prefrontal cortical glutamate efflux. Front Pharmacol 6:292","journal-title":"Front Pharmacol"},{"key":"6979_CR10","doi-asserted-by":"publisher","first-page":"792","DOI":"10.2174\/187152711798072392","volume":"10","author":"HG Bernstein","year":"2011","unstructured":"Bernstein HG, Keilhoff G, Steiner J, Dobrowolny H, Bogerts B (2011) Nitric oxide and schizophrenia. Present knowledge and emerging concepts of therapy. CNS Neurol Disord Drug Targets 10:792\u2013807","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"6979_CR11","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","volume":"35","author":"BK Bitanihirwe","year":"2011","unstructured":"Bitanihirwe BK, Woo TU (2011) Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev 35:878\u2013893","journal-title":"Neurosci Biobehav Rev"},{"key":"6979_CR12","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1038\/npp.2010.109","volume":"35","author":"A Boultadakis","year":"2010","unstructured":"Boultadakis A, Pitsikas N (2010) Effects of the nitric oxide synthase inhibitor L-NAME on recognition and spatial memory deficits produced by different NMDA receptor antagonists in the rat. Neuropsychopharmacology 35:2357\u20132366","journal-title":"Neuropsychopharmacology"},{"key":"6979_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/10715769900301161","volume":"31","author":"DS Bredt","year":"1999","unstructured":"Bredt DS (1999) Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 31:577\u2013596","journal-title":"Free Radic Res"},{"key":"6979_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0959-4388(97)80065-7","volume":"7","author":"JE Brenman","year":"1997","unstructured":"Brenman JE, Bredt DS (1997) Synaptic signaling by nitric oxide. Curr Opin Neurobiol 7:374\u2013378","journal-title":"Curr Opin Neurobiol"},{"key":"6979_CR15","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/sj.bjp.0703406","volume":"130","author":"M Bujas-Bobanovic","year":"2000","unstructured":"Bujas-Bobanovic M, Bird DC, Robertson HA, Dursun SM (2000) Blockade of phencyclidine induced effects by a nitric oxide donor. Br J Pharmacol 130:1005\u20131012","journal-title":"Br J Pharmacol"},{"key":"6979_CR16","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1023\/A:1013042817281","volume":"18","author":"MA Bush","year":"2001","unstructured":"Bush MA, Pollack GM (2001) Pharmacokinetics and pharmacodynamics of 7-nitroindazole, a selective nitric oxide synthase inhibitor, in the rat hippocampus. Pharm Res 18:1607\u20131612","journal-title":"Pharm Res"},{"key":"6979_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neuropharm.2017.11.045","volume":"142","author":"D Cadinu","year":"2018","unstructured":"Cadinu D, Grayson B, Podda G, Harte MK, Doostdar N, Neil JC (2018) NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update. Neuropharmacology 142:41\u201362","journal-title":"Neuropharmacology"},{"key":"6979_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/schbul\/9.2.247","volume":"9","author":"A Calev","year":"1983","unstructured":"Calev A, Venables PH, Monk AF (1983) Evidence for distinct verbal memory pathologies in severely and mildly disturbed schizophrenics. Schizophr Bull 9:247\u2013264","journal-title":"Schizophr Bull"},{"key":"6979_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/ph13120457","volume":"13","author":"G Caruso","year":"2020","unstructured":"Caruso G, Grasso M, Fidilio A, Tascedda F, Drago F, Caraci F (2020) Antioxidant properties of second generation antipsychotics; focus on microglia. Pharmaceuticals 13:457","journal-title":"Pharmaceuticals"},{"key":"6979_CR20","doi-asserted-by":"crossref","unstructured":"Canever L, Freire TG, Mastella GA, Dam\u00e1zio L, Gomes S, Fachim I, Michels C, Carvalho G, God\u00f3i AK, Peterle BR, Gava FF, Valvassori SS, Budni J, Quevedo J, Zugno AI (2018) Changes in behavioural parameters, oxidative stress and neurotrophins in the brain of adult offspring induced to an animal model of schizophrenia: the effects of FA deficient or FA supplemented diet during the neurodevelopmental phase. Prog Neuro-Psychopharmacol Biol Psychiatry 86:52\u201364","DOI":"10.1016\/j.pnpbp.2018.05.014"},{"key":"6979_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0031-9384(93)90148-9","volume":"53","author":"A Cavoy","year":"1993","unstructured":"Cavoy A, Delacour J (1993) Spatial but not object recognition is impaired by aging in rats. Physiol Behav 53:527\u2013530","journal-title":"Physiol Behav"},{"key":"6979_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neuropharm.2006.07.033","volume":"52","author":"BC Cheng","year":"2007","unstructured":"Cheng BC, Chang CP, Lin MT, Lee CC (2007) Inhibition of neuronal nitric oxide synthase causes attenuation of cerebrovascular dysfunction in experimental heatstroke. Neuropharmacology 52:297\u2013305","journal-title":"Neuropharmacology"},{"key":"6979_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.niox.2021.12.003","volume":"119","author":"P Cieslik","year":"2022","unstructured":"Cieslik P, Kalinowski L, Wieronska JM (2022) Procognitive activity of nitric oxide inhibitors and donors in animal models. Nitric Oxide 119:29\u201340","journal-title":"Nitric Oxide"},{"key":"6979_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/brainsci13030410","volume":"13","author":"P Cieslik","year":"2023","unstructured":"Cieslik P, Borska M, Wieronska JM (2023) A comparative study of the impact of NO-related agents on MK-801- or scopolamine-induced cognitive impairments in the Morris water maze. Brain Sci 13:410","journal-title":"Brain Sci"},{"key":"6979_CR25","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1176\/appi.ajp.160.6.1100","volume":"160","author":"SM Clinton","year":"2003","unstructured":"Clinton SM, Haroutunian V, Davis KL, Meader-Woodraff JH (2003) Altered transcript expression of NMDA-receptor associated postsynaptic proteins in the thalamus of subjects with schizophrenia. Am J Psychiatry 160:1100\u20131109","journal-title":"Am J Psychiatry"},{"key":"6979_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jneuroim.2015.02.012","volume":"281","author":"CM Comim","year":"2015","unstructured":"Comim CM, Silva NC, Patr\u00edcio JJ, Palmas D, Mendon\u00e7a BP, Bittencourt MO, Cassol OJ Jr, Barichell T, Zugno AI, Quevedo J, Dal-Pizzol F (2015) Effect of sepsis on behavioral changes on the ketamine-induced animal model of schizophrenia. J Neuroimmunol 281:78\u201382","journal-title":"J Neuroimmunol"},{"key":"6979_CR27","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2174\/0929867033456792","volume":"10","author":"A Contestabile","year":"2003","unstructured":"Contestabile A, Monti B, Contestabile A, Ciani E (2003) Brain nitric oxide and its dual effect in neuroprotection\/neurodegeneration: understanding molecular mechanisms to devise drug approaches. Curr Med Chem 10:1241\u20131253","journal-title":"Curr Med Chem"},{"key":"6979_CR28","doi-asserted-by":"crossref","unstructured":"Corssen G, Domino EF (1966) Dissociative anesthesia: Further pharmacological studies and first clinical experience with the phencyclidine derivative CI-581. Anesth Analg 45:29-40","DOI":"10.1213\/00000539-196601000-00007"},{"key":"6979_CR29","first-page":"1","volume":"16","author":"E Costa","year":"2004","unstructured":"Costa E, Davis JM, Dong E, Grayson DR, Guidotti A, Tremolizzo L, Veldic MA (2004) Gabaergic cortical deficit dominates schizophrenia pathophysiology. Crit Rev Neurobiol 16:1\u201323","journal-title":"Crit Rev Neurobiol"},{"key":"6979_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/10673229609017192","volume":"3","author":"JT Coyle","year":"1996","unstructured":"Coyle JT (1996) The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 3:241\u2013253","journal-title":"Harv Rev Psychiatry"},{"key":"6979_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0091-3057(80)90067-2","volume":"13","author":"J Crawley","year":"1980","unstructured":"Crawley J, Goodwin FK (1980) Preliminary report of a simple animal behaviour for the anxiolytic effect of benzodiazepines. Pharmacol Biochem Behav 13:167\u2013170","journal-title":"Pharmacol Biochem Behav"},{"key":"6979_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000026478","volume":"37","author":"I Das","year":"1998","unstructured":"Das I, Ramchand CN, Gliddon A, Hirsch SR (1998) Nitric oxide, free radicals and polyamines may have a role in membrane pathology of schizophrenia. Neuropsychobiology 37:65\u201367","journal-title":"Neuropsychobiology"},{"key":"6979_CR33","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1073\/pnas.88.14.6368","volume":"88","author":"VL Dawson","year":"1991","unstructured":"Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A 88:6368\u20136371","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6979_CR34","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.pnpbp.2009.05.010","volume":"33","author":"L de Oliveira","year":"2009","unstructured":"de Oliveira L, Spiazzi CM, Bortolin T, Canever L, Petronilho F, Mina FG, Dal-Pizzol F, Quevedo J, Zugno AI (2009) Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats. Prog Neuropsychopharmacol Biol Psychiatry 33:1003\u20131008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6979_CR35","doi-asserted-by":"crossref","unstructured":"Del Bel EA, Souza AS, Guimaraes FS, da-Silva CA, Nucci-da-Silva LP (2002) Motor effects of acute and chronic inhibition of nitric oxide synthesis in mice. Psychopharmacology 161:32\u201337","DOI":"10.1007\/s00213-002-1009-2"},{"key":"6979_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/0269881108097717","volume":"24","author":"EA Del Bel","year":"2010","unstructured":"Del Bel EA, Guimar\u00e3es FS, Joca SR, Echeverry MB, Ferreira FR (2010) Tolerance to the cataleptic effect that follows repeated nitric oxide synthase inhibition may be related to functional enzymatic recovery. J Psychopharmacol 24:397\u2013405","journal-title":"J Psychopharmacol"},{"key":"6979_CR37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.neubiorev.2007.01.005","volume":"31","author":"E Dere","year":"2007","unstructured":"Dere E, Huston JP, De Souza Silva MA (2007) The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev 31:673\u2013704","journal-title":"Neurosci Biobehav Rev"},{"key":"6979_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0893-133X(95)00153-5","volume":"15","author":"SI Deutsch","year":"1996","unstructured":"Deutsch SI, Rosse RB, Paul SM, Tomasino V, Koetzner L, Morn CB, Mastropaolo J (1996) 7-nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in mice. Neuropsychopharmacology 15:37\u201343","journal-title":"Neuropsychopharmacology"},{"key":"6979_CR39","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0272-7358(02)00130-7","volume":"22","author":"J Edwards","year":"2002","unstructured":"Edwards J, Jackson HJ, Pattison PE (2002) Emotion recognition via facial expression and affective prosody in schizophrenia: a methodological review. Clin Psychol Rev 22:789\u2013832","journal-title":"Clin Psychol Rev"},{"key":"6979_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","volume":"31","author":"A Ennaceur","year":"1988","unstructured":"Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. 1. Behavioral data. Behav Brain Res 31:47\u201359","journal-title":"Behav Brain Res"},{"key":"6979_CR41","doi-asserted-by":"crossref","unstructured":"Ennaceur A, Neave N, Aggleton JP (1997) Spontaneous object recognition and\u00a0object location memory in rats: The effects of lesions in the cingulated cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Exp Brain Res 113:509-519","DOI":"10.1007\/PL00005603"},{"key":"6979_CR42","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1038\/sj.npp.1301587","volume":"33","author":"K Fejgin","year":"2008","unstructured":"Fejgin K, Palsson E, Wass C, Svensson L, Klamer D (2008) Nitric oxide signaling in the medial prefrontal cortex is involved in the biochemical and behavioral effects of phencyclidine. Neuropsychopharmacology 33:1874\u20131883","journal-title":"Neuropsychopharmacology"},{"key":"6979_CR43","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.molmed.2011.08.004","volume":"17","author":"JR Field","year":"2011","unstructured":"Field JR, Walker AG, Conn PJ (2011) Targeting glutamate synapses in schizophrenia. Trends Mol Med 17:689\u2013698","journal-title":"Trends Mol Med"},{"key":"6979_CR44","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMra035458","volume":"349","author":"R Freedman","year":"2003","unstructured":"Freedman R (2003) Schizophrenia. N Engl J Med 349:1738\u20131749","journal-title":"N Engl J Med"},{"key":"6979_CR45","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/biom9060234","volume":"9","author":"K Fukuyama","year":"2019","unstructured":"Fukuyama K, Kato R, Murata M, Shiroyama T, Okada M (2019) Clozapine normalizes a glutamatergic transmission abnormality induced by an impaired NMDA receptor in the thalamocortical pathway via the activation of a group Iii metabotropic glutamate receptor. Biomolecules 9:234","journal-title":"Biomolecules"},{"key":"6979_CR46","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/336385a0","volume":"336","author":"J Garthwaite","year":"1988","unstructured":"Garthwaite J, Charles SL, Chess-Williams R (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests a role as intercellular messenger in the brain. Nature 336:385\u2013387","journal-title":"Nature"},{"key":"6979_CR47","unstructured":"Geyer MA, Markou A (1994) Animal models of psychiatric disorders. In: Bloom FE, Kupfer DL (eds) Psychopharmacology, the fourth generation of progress. Raven, New York, 787\u2013798"},{"key":"6979_CR48","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.pbb.2012.06.013","volume":"102","author":"I Gourgiotis","year":"2012","unstructured":"Gourgiotis I, Kampouri NG, Koulouri V, Lempesis IG, Prasinou MD, Georgiadou G, Pitsikas N (2012) Nitric oxide modulates apomorphine-induced recognition memory deficits in rats. Pharmacol Biochem Behav 102:507\u2013514","journal-title":"Pharmacol Biochem Behav"},{"key":"6979_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbr.2007.06.012","volume":"184","author":"B Grayson","year":"2007","unstructured":"Grayson B, Idris NF, Neill GC (2007) Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficits in the novel object recognition task in the rat. Behav Brain Res 184:31\u201338","journal-title":"Behav Brain Res"},{"key":"6979_CR50","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/schbul\/sbn081","volume":"34","author":"ES Herbener","year":"2008","unstructured":"Herbener ES (2008) Emotional memory in schizophrenia. Schizophr Bull 34:875\u2013887","journal-title":"Schizophr Bull"},{"key":"6979_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00213-011-2251-2","volume":"217","author":"M Horiguchi","year":"2011","unstructured":"Horiguchi M, Huang M, Meltzer HY (2011) Interaction of mGlu2\/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats. Psychopharmacology 217:13\u201324","journal-title":"Psychopharmacology"},{"key":"6979_CR52","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.pnpbp.2018.03.015","volume":"86","author":"AC Issy","year":"2018","unstructured":"Issy AC, dos-Santos-Pereira M, Pedrazzi JFC, Kubrusly RCC, Del-Bel E (2018) The role of striatum and prefrontal cortex in the prevention of amphetamine-induced schizophrenia-like effects mediated by nitric oxide compounds. Prog Neuropsychopharmacol Biol Psychiatry 86:353\u2013362","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6979_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0074-7742(06)78003-5","volume":"78","author":"DC Javitt","year":"2007","unstructured":"Javitt DC (2007) Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol 78:69\u2013108","journal-title":"Int Rev Neurobiol"},{"key":"6979_CR54","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","volume":"148","author":"DC Javitt","year":"1991","unstructured":"Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301\u20131308","journal-title":"Am J Psychiatry"},{"key":"6979_CR55","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0014-2999(99)00555-5","volume":"180","author":"MH Jiang","year":"1999","unstructured":"Jiang MH, Kaku T, Hada J, Hayashi Y (1999) 7-nitroindazole reduces nitric oxide concentration in rat hippocampus after transient forebrain ischemia. Eur J Pharmacol 180:117\u2013121","journal-title":"Eur J Pharmacol"},{"key":"6979_CR56","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1600-0773.1999.tb01487.x","volume":"84","author":"C Johansson","year":"1999","unstructured":"Johansson C, Deveney AM, Jackson DM (1999) The neuronal selective nitric oxide inhibitor AR-R 17477 blocks some effects of phencyclidine, while having no observable behavioural effects when given alone. Pharmacol Toxicol 84:226\u2013233","journal-title":"Pharmacol Toxicol"},{"key":"6979_CR57","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1007\/s00213-015-3951-9","volume":"232","author":"R Joules","year":"2015","unstructured":"Joules R, Doyle OM, Schwarz AJ, O\u2019Daly OG, Brammer M, Williams SC, Mehta MA (2015) Ketamine induces a robust whole brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profile. Psychopharmacology 232:4205\u20134218","journal-title":"Psychopharmacology"},{"key":"6979_CR58","doi-asserted-by":"publisher","first-page":"6866","DOI":"10.3390\/ijms24076866","volume":"24","author":"L Katsanou","year":"2023","unstructured":"Katsanou L, Fragkiadaki E, Kampouris S, Konstanta A, Vontzou A, Pitsikas N (2023) The nitric oxide (NO) donor molsidomine counteract social withdrawal and cognition deficits induced by blockade of the NMDA receptor in the rat. Int J Mol Sci 24:6866","journal-title":"Int J Mol Sci"},{"key":"6979_CR59","doi-asserted-by":"crossref","unstructured":"Khandaker GM, Cousins L, Deakin J, Lennox RB, Yolken R, Jones PB (2015)\u00a0Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry 2:258-270","DOI":"10.1016\/S2215-0366(14)00122-9"},{"key":"6979_CR60","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0031-9384(70)90107-1","volume":"5","author":"RA King","year":"1970","unstructured":"King RA, Glasser RL (1970) Duration of electroconvulsive shock induced retrograde amnesia in rats. Physiol Behav 5:335\u2013339","journal-title":"Physiol Behav"},{"key":"6979_CR61","unstructured":"Kirk RE (1968) Experimental Design: procedures for the behavioral science. Brooks\/Cole, Belmont, CA, USA"},{"key":"6979_CR62","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s00213-004-1901-z","volume":"176","author":"D Klamer","year":"2004","unstructured":"Klamer D, Palsson E, Revesz A, Engel JA, Svensson L (2004) Habituation of acoustic startle is disrupted by psychotomimetic drugs: differential dependence on dopaminergic and nitric oxide modulatory mechanisms. Psychopharmacology 176:440\u2013450","journal-title":"Psychopharmacology"},{"key":"6979_CR63","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/sj.npp.1301133","volume":"32","author":"E Koros","year":"2007","unstructured":"Koros E, Rosenbrock H, Birk G, Weiss C, Sams-Dodd F (2007) The selective mGlu5 receptor antagonist MTEP, similar to NMDA receptor antagonists, induces social isolation in rats. Neuropsychopharmacology 32:562\u2013576","journal-title":"Neuropsychopharmacology"},{"key":"6979_CR64","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremmer JD, Heninger GR, Bowers Jr., Chamey DS (1994) Sub-anesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive and neuroendocrine responses. Arch Gen Psychiatry 51:199\u2013214","journal-title":"Arch Gen Psychiatry"},{"key":"6979_CR65","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0022-3565(24)38019-X","volume":"288","author":"T Kuroki","year":"1999","unstructured":"Kuroki T, Meltzer HY, Ichikawa J (1999) Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex. J Pharmacol Exp Ther 288:774\u2013781","journal-title":"J Pharmacol Exp Ther"},{"key":"6979_CR66","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","volume":"25","author":"AC Lahti","year":"2001","unstructured":"Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25:455\u2013467","journal-title":"Neuropsychopharmacology"},{"key":"6979_CR67","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00001756-199310000-00024","volume":"5","author":"DS Lorrain","year":"1993","unstructured":"Lorrain DS, Hull EM (1993) Nitric oxide increases dopamine and serotonin release in the medial preoptic area. Neuroreport 5:87\u201389","journal-title":"Neuroreport"},{"key":"6979_CR68","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","volume":"17","author":"AK Malhotra","year":"1997","unstructured":"Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A (1997) Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17:141\u2013150","journal-title":"Neuropsychopharmacology"},{"key":"6979_CR69","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/epirev\/mxn001","volume":"30","author":"J McGrath","year":"2008","unstructured":"McGrath J, Saha S, Chant T, Welham J (2008) Schizophrenia: a concise overview of incidence, prevalence and mortality. Epidemiol Rev 30:67\u201376","journal-title":"Epidemiol Rev"},{"key":"6979_CR70","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/oxfordjournals.schbul.a033376","volume":"25","author":"HY Meltzer","year":"1999","unstructured":"Meltzer HY, McGurk SR (1999) The effects of clozapine, Risperidone and olanzapine on cognitive functions in schizophrenia. Schizophr Bull 25:235\u2013255","journal-title":"Schizophr Bull"},{"key":"6979_CR71","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1007\/s11064-020-03128-6","volume":"45","author":"S Memarpour","year":"2020","unstructured":"Memarpour S, Behesthi F, Baghchenghi Y, Vafaei AA, Hosseini M, Rashidy-Pour A (2020) Neuronal nitric oxide inhibitor 7-nitroindazole improved brain derived neurotrophic factor and attenuated brain tissues oxidative damage and learning and memory impairments of hypothyroid juvenile rats. Neurochem Res 45:2775\u20132785","journal-title":"Neurochem Res"},{"key":"6979_CR72","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic transmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921\u20132927","journal-title":"J Neurosci"},{"key":"6979_CR73","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1476-5381.1993.tb12798.x","volume":"108","author":"PK Moore","year":"1993","unstructured":"Moore PK, Babbedge RC, Wallace P, Gaffen ZA, Hart SL (1993) 7-nitroindazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol 108:296\u2013297","journal-title":"Br J Pharmacol"},{"key":"6979_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1748-1716.1985.tb07779.x","volume":"125","author":"SE Ogren","year":"1985","unstructured":"Ogren SE (1985) Evidence for a role of brain serotonergic neurotransmission in avoidance learning. Acta Physiol Scand 125:1\u201371","journal-title":"Acta Physiol Scand"},{"key":"6979_CR75","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/syn.20690","volume":"63","author":"E Palsson","year":"2009","unstructured":"Palsson E, Finnerty N, Klamer D, Wass C, Svensson L, Lowry J (2009) Increased cortical nitric oxide release after phencyclidine administration. Synapse 63:1083\u20131088","journal-title":"Synapse"},{"key":"6979_CR76","doi-asserted-by":"crossref","unstructured":"Pitsikas N (2007) Effects of scopolamine and. L-NAME on rats\u2019 performance in the\u00a0object location test. Behav Brain Res 179:294-298","DOI":"10.1016\/j.bbr.2007.02.038"},{"key":"6979_CR77","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.2174\/0929867323666160812151054","volume":"23","author":"N Pitsikas","year":"2016","unstructured":"Pitsikas N (2016) The role of nitric oxide synthase inhibitors in schizophrenia. Curr Med Chem 23:2692\u20132705","journal-title":"Curr Med Chem"},{"key":"6979_CR78","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuropharm.2014.05.008","volume":"85","author":"N Pitsikas","year":"2014","unstructured":"Pitsikas N, Markou A (2014) The metabotropic glutamate 2\/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats. Neuropharmacology 85:27\u201335","journal-title":"Neuropharmacology"},{"key":"6979_CR79","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.neuroscience.2008.04.001","volume":"154","author":"N Pitsikas","year":"2008","unstructured":"Pitsikas N, Boultadakis A, Sakellaridis N (2008) Effects of sub-anesthetic doses of ketamine on rats\u2019 spatial and non-spatial recognition memory. Neuroscience 154:454\u2013460","journal-title":"Neuroscience"},{"key":"6979_CR80","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.neuropharm.2016.10.002","volume":"113","author":"A Potasiewicz","year":"2017","unstructured":"Potasiewicz A, Holuj M, Kos T, Popik P, Arias HR, Nikiforuk A (2017) 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the \u03b17 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats. Neuropharmacology 113:188\u2013197","journal-title":"Neuropharmacology"},{"key":"6979_CR81","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/sj.npp.1301057","volume":"32","author":"F Razoux","year":"2007","unstructured":"Razoux F, Garcia R, Lena I (2007) Ketamine at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens. Neuropsychopharmacology 32:719\u2013727","journal-title":"Neuropsychopharmacology"},{"key":"6979_CR82","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/sj.mp.4001779","volume":"11","author":"A Reif","year":"2006","unstructured":"Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, Wienker T, Topner T, Fritzen S, Walter U, Schmitt A, Fallgatter A, Lesch KP (2006) A neuronal nitric oxide (NOS-1) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 11:286\u2013300","journal-title":"Mol Psychiatry"},{"key":"6979_CR83","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuroscience.2017.04.016","volume":"353","author":"GZ R\u00e9us","year":"2017","unstructured":"R\u00e9us GZ, Sim\u00f5es LR, Colpo GD, Scaini G, Oses JP, Generoso JS, Prossin AR, Kaddurah-Daouk R, Quevedo J, Barichello T (2017) Ketamine potentiates oxidative stress and influences behavior and inflammation in response to lipopolysaccharide (LPS) exposure in early life. Neuroscience 353:17\u201325","journal-title":"Neuroscience"},{"key":"6979_CR84","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/syn.20144","volume":"56","author":"RC Roberts","year":"2005","unstructured":"Roberts RC, Roche JK, Conley RR (2005) Synaptic differences in the post-mortem striatum of subjects with schizophrenia: a stereological and ultrastructural analysis. Synapse 56:185\u2013197","journal-title":"Synapse"},{"key":"6979_CR85","doi-asserted-by":"crossref","unstructured":"Rodrigues-Amorim D, Rivera-Baltan\u00e1s T, Bessa J, Sousa N, Vallejo-Curto MC,\u00a0Rodr\u00edguez-Jamardo C, de Las Heras ME, D\u00edaz R, Ag\u00eds-Balboa RC, Olivares JM, Spuch C (2018) The Neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: a meta-analysis. J Psychiatr Res 106:43\u201353","DOI":"10.1016\/j.jpsychires.2018.09.007"},{"key":"6979_CR86","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.neuropharm.2012.04.032","volume":"63","author":"NL Roenker","year":"2012","unstructured":"Roenker NL, Gudelsky GA, Ahlbrand R, Horn PS, Richtand NM (2012) Evidence for involvement of nitric oxide and GABAB receptors in MK-801-stimulated release of glutamate in the rat prefrontal cortex. Neuropharmacology 63:575\u2013581","journal-title":"Neuropharmacology"},{"key":"6979_CR87","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00008877-199601000-00001","volume":"7","author":"F Sams-Dodd","year":"1996","unstructured":"Sams-Dodd F (1996) Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia. Behav Pharmacol 7:3\u201323","journal-title":"Behav Pharmacol"},{"key":"6979_CR88","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/(SICI)1520-6394(1997)5:1<29::AID-DA5>3.0.CO;2-0","volume":"5","author":"JS Silvestre","year":"1997","unstructured":"Silvestre JS, Nadal R, Pallares M, Ferre E (1997) Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats. Depress Anxiety 5:29\u201333","journal-title":"Depress Anxiety"},{"key":"6979_CR89","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0006-8993(00)03109-7","volume":"889","author":"JCE Smith","year":"2001","unstructured":"Smith JCE, Whitton PS (2001) The regulation of the NMDA-evoked dopamine release by nitric oxide in the frontal cortex and Raphe nuclei of the freely moving rat. Brain Res 889:57\u201362","journal-title":"Brain Res"},{"key":"6979_CR90","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/sj.bjp.0703273","volume":"130","author":"DK Song","year":"2000","unstructured":"Song DK, Im YB, Jung JS, Ya JJ, Huh SO, Suh HW, Kim YH (2000) Central injection of nitric oxide synthase inhibitors increases peripheral interleukin-6 and serum amyloid A: involvement of adrenaline from adrenal medulla. Br J Pharmacol 130:41\u201348","journal-title":"Br J Pharmacol"},{"key":"6979_CR91","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/2045125314557797","volume":"5","author":"H Steeds","year":"2015","unstructured":"Steeds H, Carhart-Harris RL, Stone JM (2015) Drug models of schizophrenia. Ther Adv Psychopharmacol 5:43\u201358","journal-title":"Ther Adv Psychopharmacol"},{"key":"6979_CR92","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00213-015-4181-x","volume":"233","author":"A Trevlopoulou","year":"2016","unstructured":"Trevlopoulou A, Touzlatzi N, Pitsikas N (2016) The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats. Psychopharmacology 233:1045\u20131054","journal-title":"Psychopharmacology"},{"key":"6979_CR93","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0014-2999(89)90754-1","volume":"167","author":"MD Tricklebank","year":"1989","unstructured":"Tricklebank MD, Singh L, Oles RJ, Preston C, Iversen SD (1989) The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 167:127\u2013135","journal-title":"Eur J Pharmacol"},{"key":"6979_CR94","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bbr.2011.01.052","volume":"220","author":"FJ Van der Staay","year":"2011","unstructured":"Van der Staay FJ, Rutten K, Erb C, Blokland A (2011) Effects of the cognition impairer MK-801 on learning and memory in mice and rats. Behav Brain Res 220:215\u2013229","journal-title":"Behav Brain Res"},{"key":"6979_CR95","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1002\/ptr.8266","volume":"38","author":"F Vartzoka","year":"2024","unstructured":"Vartzoka F, Parlantza MA, Tarantilis PA, Pitsikas N (2024) Co-administration of sub-threshold doses of the constituents of Crocus sativus L., crocins with those of the antipsychotics clozapine and risperidone counteract memory deficits caused by blockade of the NMDA receptor in rats. Phytother Res 38:4140\u20134150","journal-title":"Phytother Res"},{"key":"6979_CR96","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1523\/JNEUROSCI.16-01-00373.1996","volume":"16","author":"A Verma","year":"1996","unstructured":"Verma A, Moghaddam B (1996) NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 16:373\u2013379","journal-title":"J Neurosci"},{"key":"6979_CR97","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0893-133X(98)00008-6","volume":"19","author":"JL Wiley","year":"1998","unstructured":"Wiley JL (1998) Nitric oxide synthase inhibitors attenuate phencyclidine-induced disruption of prepulse inhibition. Neuropsychopharmacology 19:86\u201394","journal-title":"Neuropsychopharmacology"},{"key":"6979_CR98","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1248\/bpb.b18-00633","volume":"41","author":"T Yamakawa","year":"2018","unstructured":"Yamakawa T, Kurauchi Y, Hisatsune A, Seki T, Katsuki H (2018) Endogenous nitric oxide inhibits, whereas awakening stimuli increase, the activity of a subset of orexin neurons. Biol Pharm Bull 41:1859\u20131865","journal-title":"Biol Pharm Bull"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06979-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-025-06979-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06979-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:04:25Z","timestamp":1792537465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-025-06979-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":98,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["6979"],"URL":"https:\/\/doi.org\/10.1007\/s00213-025-06979-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The procedures that involved animals and their care were conducted in accordance with international guidelines and national (Animal Act, P.D. 160\/91) and international laws and policies (EU Directive 2010\/63). Experiments were approved by the local committee (Prefecture of Larissa, Greece, protocol number 386501\/2023). Every effort was made to minimize the number of animals used and their suffering.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read, edited, and approved the final version of the manuscript.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}